Literature DB >> 16949775

Preparation and in vitro and in vivo characterization of composite microcapsules for cell encapsulation.

Paolo Blasi1, Stefano Giovagnoli, Aurélie Schoubben, Maurizio Ricci, Carlo Rossi, Giovanni Luca, Giuseppe Basta, Riccardo Calafiore.   

Abstract

Cell encapsulation technology raises great hopes in medicine and biotechnology. Transplantation of encapsulated pancreatic islets represents a promising approach to the final cure of type 1 diabetes mellitus. Unfortunately, long-term graft survival and functional competence remain only partially fulfilled. Failure was often ascribed to the lack of biocompatibility generating inflammatory response, limited immunobarrier competence, hypoxia, and low beta-cell replication. In the present work, ketoprofen loaded biodegradable microspheres, embedded into alginate/poly-L-ornithine/alginate microcapsules, were prepared in order to release ketoprofen at early stages after implantation. Morphology, size, in vitro release behaviour, and in vivo biocompatibility were assessed. The effect of some preparation parameters was also evaluated. Polymeric microspheres were spherical and smooth, two populations of about 5 and 20 microm of mean diameter characterized the particle size distribution. A high burst effect was observed for all preparations during in vitro release studies. Ketoprofen, plasticizing the polymeric matrix, could be responsible of this release behaviour. Alginate/poly-L-ornithine/alginate microcapsules were not modified upon ketoprofen loaded microspheres encapsulation and an optimal dispersion was obtained. Composite system showed good biocompatibility when a high molecular weight polymer was employed. Therefore a potentially suitable composite system for cell encapsulation was obtained. This system may be successfully used to release NSAIDs and other active molecules capable to improve cell system functional performance and life-span.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949775     DOI: 10.1016/j.ijpharm.2006.07.049

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

Review 1.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

Review 2.  Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases.

Authors:  Ursula Matte; Valeska Lizzi Lagranha; Talita Giacomet de Carvalho; Fabiana Quoos Mayer; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-05-26       Impact factor: 4.982

3.  Bioactive long-term release from biodegradable microspheres preserves implanted ALG-PLO-ALG microcapsules from in vivo response to purified alginate.

Authors:  Stefano Giovagnoli; Paolo Blasi; Giovanni Luca; Francesca Fallarino; Mario Calvitti; Francesca Mancuso; Maurizio Ricci; Giuseppe Basta; Ennio Becchetti; Carlo Rossi; Riccardo Calafiore
Journal:  Pharm Res       Date:  2009-12-31       Impact factor: 4.200

4.  Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug.

Authors:  Tram T Dang; Anh V Thai; Joshua Cohen; Jeremy E Slosberg; Karolina Siniakowicz; Joshua C Doloff; Minglin Ma; Jennifer Hollister-Lock; Katherine M Tang; Zhen Gu; Hao Cheng; Gordon C Weir; Robert Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2013-05-07       Impact factor: 12.479

5.  Microencapsulation of bioactive principles with an airless spray-gun suitable for processing high viscous solutions.

Authors:  Moreno Cocchietto; Paolo Blasi; Romano Lapasin; Chiara Moro; Davide Gallo; Gianni Sava
Journal:  J Funct Biomater       Date:  2013-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.